Jan 5, 2023
It’s weird it’s happened 10 times right?
Loading...
seen from Israel
seen from Dominican Republic
seen from China
seen from Israel
seen from Singapore
seen from Germany
seen from United States
seen from United States
seen from United Kingdom
seen from Senegal
seen from United States
seen from Denmark
seen from Indonesia
seen from Australia
seen from China
seen from United States
seen from China
seen from China
seen from United States
seen from Dominican Republic
It’s weird it’s happened 10 times right?
Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
Odd Girl Out
"Threesome" changes to "trio", which is frankly a better match even besides. But this poses that recurring question of when a word accrues the connotation and meaning in such overwhelming fashion as to see it is to have it stick out enough to change it. Here, it is sometime after 1998.
Deciding not to get cute on "show biz" and decide "madhouse" is one word.
Did a actual fight just break out on the fucking Congress floor?!
Jefferies
the Republicans need to sit down and stop clapping at everything
Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
Drugmaker Johnson & Johnson must pay $572m (£468m) for its part in fuelling Oklahoma's opioid addiction crisis, a judge in the US state has ruled. The company said immediately after the judgement that it would appeal. Earlier this year, Oklahoma settled with OxyContin maker Purdue Pharma for $270m and Teva Pharmaceutical for $85m, leaving Johnson & Johnson as the lone defendant. The outcome of the case is being closely watched by plaintiffs in about 2,000 opioid lawsuits due to go to trial in Ohio in October, unless the parties can reach a settlement. The company's share price rose following the ruling because investors had been expecting a much bigger fine. Jared Holz, healthcare strategist for financial services company Jefferies, said: "The expectation was this was going to be a $1.5bn to $2bn fine, and $572m is a much lower number than had been feared."
Russell Hotten, 'Opioid crisis: Johnson & Johnson hit by landmark ruling', BBC
